Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Patient Drug Response Using an Ex Vivo Organ Culture (EVOC) on Fresh Human Tumour Samples From Metastatic Patients

NCT04599608 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04599608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04599608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Patient Drug Response Using an Ex Vivo Organ Culture (EVOC) on Fresh Human Tumour Samples From Metastatic Patients
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2021
Completion date
January 31, 2026
Enrollment
248 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, metastatic cancer